Sensei Biotherapeutics, Inc. · NASDAQ:SNSE

S2G Investments, LLC reported a 9.99% stake in Sensei Biotherapeutics, Inc. (Schedule 13G)

Event Jun 15, 2026 · Filed Jun 23, 2026

S2G Investments, LLC reported a 9.99% stake in Sensei Biotherapeutics, Inc., 2,575,401 shares, as a passive investor on Jun 15, 2026. Filed Jun 23, 2026 (Schedule 13G).

Stake
9.99%
Shares
2,575,401
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
S2G Investments, LLC9.99%2,575,401

Source

View original at SEC

Related